Absci CEO Builds Biotech's Next Big Thing
A CEO aims to make new medicines faster, much like how tech companies make new phones.
Sean McClain started Absci from his parents' home. Now, he leads a company changing how we make drugs. He wants to make medicine as easy to get as new tech gadgets.
Today, medicines for weight loss, like GLP-1 drugs, are very popular. These drugs show that people want control over their health. They are ready to spend money on medicines that help them feel better.
McClain sees a future where making drugs is faster and smarter. He uses AI to find new drug ideas. This helps make better medicines more quickly. It means new treatments can reach people sooner.
This new way of working could change everything. It helps bring needed medicines from labs to homes faster. This helps people live healthier lives.
Source: FierceBiotech
More from Biotech
